Specifically, on the basis of previous understanding of the role of the TLR4 and NLRP3 signaling pathways in SIRS-associated liver injury [8, 20], the present study hypothesized that these signaling pathways are also closely associated with SIRS-associated intestinal damage. The gene discussed is NLRP3; the disease is systemic inflammatory response syndrome.